0.0004USD0.00%Mkt Cap: 16833 USDP/E: —Last update: 2026-05-22
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signa…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap16.83K USD
Enterprise Value-1.40M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.61M USD
Revenue/Share—
Last Price0.0004 USD
Fiscal Year EndDec 2022
MR QuarterJun 2023
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.15
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.41
EPS (Forward)-1.23
52W Range
0.00031% of range0.0100
52W High0.0100 USD
52W Low0.0003 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE176.86%
ROA-2959.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.13M USD
CapEx (TTM)1.55K USD
FCF Margin—
FCF Yield2913.37%
Net Debt-362.10K USD
Net Debt/EBITDA0.04
Balance Sheet
Debt/Equity—
Current Ratio0.04
Quick Ratio0.03
Book Value/Sh-0.2380 USD
Cash/Share0.0090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.08M
Float34.22M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float0.25%
Short % Out.0.11%
Shares Short23.77K
Short (prev mo.)19.47K
Technical
SMA 500.0004 (-8.3%)
SMA 2000.0004 (-5.4%)
Beta31.08
S&P 52W Chg28.31%
Avg Vol (30d)1.19K
Avg Vol (10d)418
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—